Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-News: Cryptology's estimated NAV per share as of 29/12/2021 is €10.03 as Hauck & Aufhäuser updates Cryptology 'Buy' Rating to €13.00
DGAP-News: Cryptology's estimated NAV per share as of 29/12/2021 is €10.03 as Hauck & Aufhäuser updates Cryptology 'Buy' Rating to €13.00
DGAP-News: Cryptology's estimated NAV per share as of 29/12/2021 is €10.03 as Hauck & Aufhäuser updates Cryptology 'Buy' Rating to €13.00
Turkiye Garanti Bankasi A.S.: Coupon Rate of  Bank Bonds to Qualified Investors
Turkiye Garanti Bankasi A.S.: Coupon Rate of Bank Bonds to Qualified Investors
Turkiye Garanti Bankasi A.S.: Coupon Rate of Bank Bonds to Qualified Investors
Photon Energy Group Leads Series A Equity Round in Lerta
Photon Energy Group Leads Series A Equity Round in Lerta
Photon Energy Group Leads Series A Equity Round in Lerta
NCSP Group's consolidated cargo turnover for 11M 2021 increased by 3.8%
NCSP Group's consolidated cargo turnover for 11M 2021 increased by 3.8%
NCSP Group's consolidated cargo turnover for 11M 2021 increased by 3.8%
EQS-Adhoc: Polyphor closes merger with EnBiotix and is renamed Spexis
EQS-Adhoc: Polyphor closes merger with EnBiotix and is renamed Spexis
EQS-Adhoc: Polyphor closes merger with EnBiotix and is renamed Spexis
EQS-Adhoc: Cosmo Pharmaceuticals Announces Hiring of Head of Investor Relations and Senior Leadership Change
EQS-Adhoc: Cosmo Pharmaceuticals Announces Hiring of Head of Investor Relations and Senior Leadership Change
EQS-Adhoc: Cosmo Pharmaceuticals Announces Hiring of Head of Investor Relations and Senior Leadership Change
EQS-Adhoc: Relief Reports U.S. Collab. Partner Announces Filing Breakthrough Therapy Request for Aviptadil in Pts at Immediate Risk of Death from COVID-19 Despite Treatment w/Remdesivir, Other Approved Therapies
EQS-Adhoc: Relief Reports U.S. Collab. Partner Announces Filing Breakthrough Therapy Request for Aviptadil in Pts at Immediate Risk of Death from COVID-19 Despite Treatment w/Remdesivir, Other Approved Therapies
EQS-Adhoc: Relief Reports U.S. Collab. Partner Announces Filing Breakthrough Therapy Request for Aviptadil in Pts at Immediate Risk of Death from COVID-19 Despite Treatment w/Remdesivir, Other Approved Therapies
Sistema PJSFC:  Sistema reports acquisition of shares under buyback programme
Sistema PJSFC: Sistema reports acquisition of shares under buyback programme
Sistema PJSFC: Sistema reports acquisition of shares under buyback programme
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Ultra Electronics Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Stagecoach Group plc
Form 8.3 - The Vanguard Group, Inc.: Stagecoach Group plc
Form 8.3 - The Vanguard Group, Inc.: Stagecoach Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Sanne Group plc
Form 8.3 - The Vanguard Group, Inc.: Playtech plc
Form 8.3 - The Vanguard Group, Inc.: Playtech plc
Form 8.3 - The Vanguard Group, Inc.: Playtech plc
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: National Express Group plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Form 8.3 - The Vanguard Group, Inc.: Meggitt plc
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Rights and Issues Investment Trust PLC: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Sistema PJSFC: Sistema completes sale of minority stake in Segezha Group
Sistema PJSFC: Sistema completes sale of minority stake in Segezha Group
Sistema PJSFC: Sistema completes sale of minority stake in Segezha Group
Sberbank: ​​​​​​​One thousand key employees to become Sber shareholders
Sberbank: ​​​​​​​One thousand key employees to become Sber shareholders
Sberbank: ​​​​​​​One thousand key employees to become Sber shareholders
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
Travis Perkins: Transaction in Own Shares
EQS-Adhoc: Polyphor to inform about the financing of its merger partner EnBiotix
EQS-Adhoc: Polyphor to inform about the financing of its merger partner EnBiotix
EQS-Adhoc: Polyphor to inform about the financing of its merger partner EnBiotix
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Vivo Energy plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
Form 8.3 - The Vanguard Group, Inc.: Avast plc
SHAREHOLDERS OF NORNICKEL APPROVED THE DIVIDEND FOR 9 MONTHS OF 2021
SHAREHOLDERS OF NORNICKEL APPROVED THE DIVIDEND FOR 9 MONTHS OF 2021
SHAREHOLDERS OF NORNICKEL APPROVED THE DIVIDEND FOR 9 MONTHS OF 2021
PJSC RusHydro: Results of the Board of Directors Meeting on December 28, 2021
PJSC RusHydro: Results of the Board of Directors Meeting on December 28, 2021
PJSC RusHydro: Results of the Board of Directors Meeting on December 28, 2021
XTPL S.A.: Scientists from the Italian University in Brescia acquire the Delta Printing System from XTPL S.A. for application in biosensors and bioelectronics for next-generation biomedicine
XTPL S.A.: Scientists from the Italian University in Brescia acquire the Delta Printing System from XTPL S.A. for application in biosensors and bioelectronics for next-generation biomedicine
XTPL S.A.: Scientists from the Italian University in Brescia acquire the Delta Printing System from XTPL S.A. for application in biosensors and bioelectronics for next-generation biomedicine